RU93020706A - METHOD FOR EXTRACORPORAL REGENERATION OF PLASMA OBTAINED AFTER PLASMAPHERESIS - Google Patents

METHOD FOR EXTRACORPORAL REGENERATION OF PLASMA OBTAINED AFTER PLASMAPHERESIS

Info

Publication number
RU93020706A
RU93020706A RU93020706/14A RU93020706A RU93020706A RU 93020706 A RU93020706 A RU 93020706A RU 93020706/14 A RU93020706/14 A RU 93020706/14A RU 93020706 A RU93020706 A RU 93020706A RU 93020706 A RU93020706 A RU 93020706A
Authority
RU
Russia
Prior art keywords
plasmapheresis
extracorporal
regeneration
plasma
plasma obtained
Prior art date
Application number
RU93020706/14A
Other languages
Russian (ru)
Other versions
RU2033190C1 (en
Inventor
А.А. Полиров
Н.М. Федоровский
Original Assignee
А.А. Полиров
Н.М. Федоровский
Filing date
Publication date
Application filed by А.А. Полиров, Н.М. Федоровский filed Critical А.А. Полиров
Priority to RU93020706A priority Critical patent/RU2033190C1/en
Priority claimed from RU93020706A external-priority patent/RU2033190C1/en
Application granted granted Critical
Publication of RU2033190C1 publication Critical patent/RU2033190C1/en
Publication of RU93020706A publication Critical patent/RU93020706A/en

Links

Claims (1)

Изобретение относится к медицине, в частности к интенсивной терапии. Проводят экстракорпоральное восстановление плазмы крови. В плазму, полученную методом плазмафереза, добавляют раствор гипохлорита натрия, концентрацией 1200 мг% в объемном соотношении 10/1 и выдерживают в течение 4 - 16 ч. Время экспонирования определяют при динамическом контроле за изменениями эффективно концентрации альбумина. Способ позволяет реинфузировать плазму больного и сократить потребности в донорских белковых препаратах.The invention relates to medicine, in particular to intensive care. Extracorporeal restoration of blood plasma is performed. Sodium hypochlorite solution with a concentration of 1200 mg% in a volume ratio of 10/1 is added to the plasma obtained by plasmapheresis and kept for 4-16 hours. The exposure time is determined by dynamically monitoring changes in the effective concentration of albumin. The method allows to reinfuse the patient’s plasma and reduce the need for donor protein preparations.
RU93020706A 1993-04-21 1993-04-21 Method for extracorporal regeneration of plasma after plasmapheresis RU2033190C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93020706A RU2033190C1 (en) 1993-04-21 1993-04-21 Method for extracorporal regeneration of plasma after plasmapheresis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93020706A RU2033190C1 (en) 1993-04-21 1993-04-21 Method for extracorporal regeneration of plasma after plasmapheresis

Publications (2)

Publication Number Publication Date
RU2033190C1 RU2033190C1 (en) 1995-04-20
RU93020706A true RU93020706A (en) 1996-11-10

Family

ID=20140647

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93020706A RU2033190C1 (en) 1993-04-21 1993-04-21 Method for extracorporal regeneration of plasma after plasmapheresis

Country Status (1)

Country Link
RU (1) RU2033190C1 (en)

Similar Documents

Publication Publication Date Title
Hirasawa et al. Blood purification for prevention and treatment of multiple organ failure
Gottschalk et al. History of the science of dialysis
Katirtzoglou et al. Reappraisal of protein losses in patients undergoing continuous ambulatory peritoneal dialysis
DE69829721D1 (en) Use of activated protein C for the treatment of excessive blood clotting in sepsis
IT1241588B (en) BLOOD PURIFICATION EQUIPMENT, PARTICULARLY FOR THE TREATMENT OF PATIENTS WITH RENAL INSUFFICIENCY, AND PROCEDURE FOR THE PRODUCTION OF REINFUSION LIQUID FOR HEMODIAFILTRATION (HDF)
Ing et al. First-use syndrome with cuprammonium cellulose dialyzers
Nakazawa et al. A new treatment for dialysis-related amyloidosis with β 2-microglobulin adsorbent column
SE8506029D0 (en) HEART-LUNGE SYSTEM PROVIDED FOR ACIDING A PATIENT'S BLOOD
Matzke et al. Disposition of vancomycin during hemofiltration
US5261876A (en) Enhanced peritoneal membrane plasmapheresis
NO20000087L (en) Treatment of inflammatory diseases of the intestine and bladder
Caruana et al. Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysis
RU93020706A (en) METHOD FOR EXTRACORPORAL REGENERATION OF PLASMA OBTAINED AFTER PLASMAPHERESIS
Canaud et al. Hemodiafiltration using dialysate as substitution fluid
Reetze-Bonorden et al. Elimination of vancomycin in patients on continuous arteriovenous hemodialysis
Johnston Possible transmission of malaria by renal transplantation.
Hwang et al. Dialytic ascitic ultrafiltration in refractory ascites.
Sherman et al. Acute therapy of hemodialysis-related muscle cramps
Floege et al. Which Membrane?
Kowalewski et al. The elimination of free, peptide-bound and protein-bound hydroxyproline into dialysate during peritoneal dialysis in patients with renal failure
RU2203066C2 (en) Method for body detoxication
Bocci et al. Ozonation of blood during extracorporeal circulation II. Comparative analysis of several oxygenator-ozonators and selection of one type
Lee et al. ß2-Microglobulin Clearance with Super High Flux Hemodialysis: an Ex Vivo Study
Aljama et al. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes
RU2148991C1 (en) Dialyzing disintoxicating solution for carrying out dialysis with sorption effect in suppurative surgery